Lineage Cell Therapeutics, Inc. (LCTX)
1.70
+0.06
(+3.66%)
USD |
NYAM |
Apr 17, 16:00
1.69
-0.01
(-0.59%)
After-Hours: 20:00
Lineage Cell Therapeutics Market Cap : 423.45M for April 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| SIGA Technologies, Inc. | 339.95M |
| Pacira Biosciences, Inc. | 1.002B |
| Niagen Bioscience, Inc. | 387.59M |
| Strata Critical Medical, Inc. | 397.11M |
| Prime Medicine, Inc. | 689.71M |
Market Cap Related Metrics
| PS Ratio | 27.05 |
| PEG Ratio | -0.0328 |
| Price to Book Value | 9.505 |
| Price | 1.70 |
| Earnings Yield | -16.37% |
| PEGY Ratio | -0.0328 |